TLR2 and metabolic dysfunction-associated steatohepatitis: As expected, SC and ART treatment significantly decreased the intestinal mRNA levels of inflammatory cytokines such as Tlr4, Tlr2, and Il-6 in NASH mice (Figure 7B).